C. Spencer

发表

Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

K. Mcclellan, C. Spencer, K. McClellan, 1998, CNS drugs.

Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer.

L. Wiseman, C. Spencer, 1997, Drugs & aging.

Bicalutamide in Advanced Prostate Cancer

K. Goa, C. Spencer, Karen L. Goa, 1998 .

Management of Narcolepsy

A. Comer, C. Spencer, 2000 .

Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder

G. Keating, C. Spencer, N. S. Gunasekara, 2002, CNS drugs.

Prednicarbate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.

C. Spencer, A. Wagstaff, 1998, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Topical fluticasone propionate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.

L. Wiseman, C. Spencer, A. Wagstaff, 1997, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Ebastine

C. Spencer, M. Hurst, 2000, Drugs.

Estradiol-Intranasal

C. Spencer, D. Ormrod, Mukta Dooley, 2012, Drugs.

Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.

D. Faulds, C. Spencer, 1992, Drugs.

Insulin Aspart

C. Spencer, K. Simpson, 2012, Drugs.

Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.

C. Spencer, N. Bhana, Nila Bhana, 2000, Drugs & aging.

Irbesartan: an updated review of its use in cardiovascular disorders.

A. Markham, C. Spencer, B. Jarvis, 2000, Drugs.

Quetiapine : A Review of its Use in Schizophrenia.

C. Spencer, N. S. Gunasekara, C. M. Spencer, 1998, CNS drugs.

Raloxifene: a review of its use in postmenopausal osteoporosis.

C. Spencer, D. Clemett, 2000, Drugs.

Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers.

L. Wiseman, C. Spencer, 1998, Drugs & aging.

Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

D. Faulds, C. Spencer, 1994, Drugs.

Aceclofenac

C. Spencer, C. Dunn, M. Dooley, 2012, Drugs.

Reboxetine: A Review of its Use in Depression

C. Spencer, K. Holm, 1999 .

Ropinirole: a review of its use in the management of Parkinson's disease.

C. Spencer, A. Matheson, 2000, Drugs.

Entacapone. A review of its use in Parkinson's disease.

C. Spencer, K. Holm, 1999, Drugs.

Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.

C. Spencer, C. Dunn, 1995, Drugs & aging.

Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.

L. Wiseman, C. Spencer, 1998, Drugs.

Topotecan: a review of its efficacy in small cell lung cancer.

C. Spencer, D. Ormrod, 1999, Drugs.

Nisoldipine Coat-Core

C. Spencer, H. Langtry, H. D. Langtry, 1997, Drugs.

Enoxaparin. A review of its clinical potential in the management of coronary artery disease.

C. Spencer, S. Noble, 1998, Drugs.

Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Sanjay S. Patel, C. Spencer, S. Patel, 1996, Drugs & aging.

Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.

L. Scott, C. Spencer, 2000, Drugs.

Salmeterol/Fluticasone Propionate Combination

C. Spencer, B. Jarvis, 1999, Drugs.

- Drugs & Therapy Perspectives

K. Goa, G. Plosker, C. Spencer, 1996 .

Cetirizine : A Reappraisal of its Pharmacological Properties and Therapeutic Use in Selected Allergic Disorders.

D. Faulds, D. Peters, C. Spencer, 1993, Drugs.

Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.

D. McTavish, C. Spencer, 1995, Drugs.

Management of Acute Otitis Media

H. Lamb, C. Spencer, 2000 .

Tropisetron

C. Spencer, K. Simpson, K. McClellan, 2000, Drugs.

Amifostine

C. Spencer, C. Culy, Caroline M. Spencer, 2012, Drugs.

Edrecolomab (Monoclonal Antibody 17-1A)

C. Spencer, J. Adkins, 1998, Drugs.

Spotlight on Estradiol-Intranasal in the Management of Menopause

C. Spencer, Mukta Dooley, D. Ormrod, 2002, Treatments in endocrinology.

Recombinant Factor VIIa

C. Spencer, C. Dunn, 1999, BioDrugs.

Cetirizine: a review of its use in children with allergic disorders.

C. Spencer, S. Noble, 1999, Paediatric drugs.

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.

C. Spencer, A. Coukell, 1997, Drugs.

Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium.

K. Goa, C. Spencer, 1996, Drugs.

Iodixanol : A Review of its Pharmacodynamic and Pharmacokinetic Properties and Diagnostic Use as an x-Ray Contrast Medium.

K. Goa, C. Spencer, 1996, Drugs.

Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.

C. Spencer, H. Bryson, 1995, PharmacoEconomics.

Topical Fluticasone Propionate

L. Wiseman, C. Spencer, 1997, BioDrugs.

Zolmitriptan: a review of its use in migraine.

C. Spencer, N. S. Gunasekara, C. Hills, 1999, Drugs.

Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

K. Goa, C. Spencer, J. C. Gillis, 1997, Drugs.

Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

C. Spencer, S. Patel, C. M. Spencer, 1996, Drugs.

Sevoflurane in Paediatric Anaesthesia

K. Goa, C. Spencer, S. Noble, 1999, Paediatric drugs.

Miglitol

C. Spencer, Lesley J. Scott, 2000, Drugs.

Rivastigmine. A review of its use in Alzheimer's disease.

C. Spencer, S. Noble, 1998, Drugs & aging.

Management of Hypertension in Patients with Diabetes Mellitus

C. Spencer, B. Jarvis, 2000 .

Live Oral Cholera Vaccine

C. Spencer, Rick Davis, 1995, Clinical Immunotherapeutics.

Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.

R. N. Brogden, C. Spencer, 1997, Drugs.

Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections.

K. Goa, C. Spencer, 1995, Drugs.

Amifostine

K. Goa, C. Spencer, Caroline M. Spencer, 2012, Drugs.

Interferon-α-2a

C. Spencer, J. Balfour, 1995, Clinical Immunotherapeutics.

Insulin aspart. Commentaries

L. Heinemann, P. Home, C. Spencer, 1999 .

Anagrelide

R. N. Brogden, C. Spencer, 2012, Drugs.

Milnacipran

C. Spencer, M. Wilde, Caroline M. Spencer, 2012, Drugs.

Tianeptine

C. Spencer, A. Wagstaff, D. Ormrod, 2001, CNS Drugs.

Clobetasol Propionate Foam, 0.05%

C. Spencer, B. Jarvis, E. Melian, 2001, American journal of clinical dermatology.

Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.

D. McTavish, C. Spencer, 1995, Drugs.

Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer.

C. Spencer, B Fulton, C M Spencer, 1996, Drugs.

Metrifonate: A review of its use in Alzheimer's disease

C. Spencer, D. Ormrod, 2000 .

Raloxifene

C. Spencer, D. Clemett, 2000, Drugs.

Management of Dyslipidaemias

C. Spencer, M. Wilde, 1998 .

Bupropion

C. Spencer, K. Holm, K. J. Holm, 2000, Drugs.

Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

C. Spencer, L. Barradell, 1996, Drugs.

Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure.

D. Faulds, C. Spencer, A. Fitton, 1993, Drugs & aging.

A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Schizophrenia

P. Benfield, C. Spencer, A. Coukell, 1996 .

Unoprostone (Isopropyl Unoprostone)

C. Spencer, M. Haria, 1996, Drugs & aging.

Alendronate: an update of its use in osteoporosis.

C. Spencer, M. Sharpe, S. Noble, 2001, Drugs.

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders.

D. Faulds, D. Peters, C. Spencer, 1993, Drugs.

Milnacipran

C. Spencer, M. Wilde, 2022, Reactions Weekly.

Ziprasidone

G. Keating, C. Spencer, N. S. Gunasekara, 2012, Drugs.

Abecarnil in Generalised Anxiety Disorder

P. Benfield, C. Spencer, 1995 .

Gemtuzumab ozogamicin

C. Spencer, J. K. McGavin, 2012, Drugs.

Assisted Circulation 2

K. Affeld, J. T. Watson, D. B. Olsen, 1984, Springer Berlin Heidelberg.

Cefotaxime

R. N. Brogden, C. Spencer, Rex N. Brogden, 1997, Drugs.

Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium.

K. Goa, C. Spencer, 1996, Drugs.

Bicalutamide in advanced prostate cancer. A review.

K. Goa, C. Spencer, 1998, Drugs & Aging.

Irbesartan

A. Markham, C. Spencer, B. Jarvis, 2000, Drugs.

Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemia.

R. N. Brogden, C. Spencer, 1994, Drugs.

Tianeptine

C. Spencer, A. Wagstaff, D. Ormrod, 2001, CNS drugs.

Irbesartan

A. Markham, C. Spencer, B. Jarvis, 2000, Drugs.

Latanoprost

Sanjay S. Patel, C. Spencer, 1996 .

Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.

D. Faulds, C. Spencer, 1992, Drugs.

Dexrazoxane

L. Wiseman, C. Spencer, 2012, Drugs.

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders.

D. Faulds, C. Spencer, David, 1993, Drugs.

Rivastigmine

C. Spencer, S. Noble, 1998 .

Metrifonate

C. Spencer, D. Ormrod, 2000 .

Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.

C. Spencer, K. Simpson, K. McClellan, 2000, Drugs.

Zolmitriptan

C. Spencer, N. S. Gunasekara, Carol Hills, 1999, Drugs.